Skip to content

Pitney Bowes PBI Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

GitLab logo
GitLabGTLB
$507.71M+70.9%
Liberty Global logo
Liberty GlobalLBTYB
$46.3M-40.6%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$157.34M
Planet Fitness logo
Planet FitnessPLNT
$196.86M+4.2%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$348.72M+58.6%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$111.66M

Other financials

Income statement

See full
Revenue$477.4M-3.2%
Gross profit$271.7M
Net income$58.1M+64.1%
EPS (diluted)$0.39+105%

Balance sheet

See full
Cash & equivalents$86.5M-73.3%
Total debt$2.3B+11.1%
Total equity-$893.6M-66.7%
Total assets$3.1B-3.7%

Cash flow

See full
Operating cash flow$44.2M+365%
CapEx$15.8M-6.2%
Free cash flow$28.3M+184%

Valuation

See full
Market cap$2.35B-0.3%
Enterprise value$4.53B+13.6%
P/E14.1×
P/S1.3×+0.1×

Profitability

See full
Gross margin30.5%
Net margin8.9%+6.0pp
FCF margin20.2%+12.4pp

Returns & leverage

See full
Return on equity11%-80.1pp
Debt / equity41.4×+14.6×
Current ratio0.6×-0.2×

Where this comes from

Reported directly by Pitney Bowes in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Pitney Bowes’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pitney Bowes's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pitney Bowes's cash, cash equivalents, and marketable securities?
Pitney Bowes (PBI) reported cash, cash equivalents, and marketable securities of $165.96M in Q1 2026.
How has Pitney Bowes's cash, cash equivalents, and marketable securities changed year-over-year?
Pitney Bowes's cash, cash equivalents, and marketable securities increased by 9.4% year-over-year, from $151.73M to $165.96M.
What is the long-term trend for Pitney Bowes's cash, cash equivalents, and marketable securities?
Over 5 years (2020 to 2025), Pitney Bowes's cash, cash equivalents, and marketable securities has grown at a 4.6% compound annual growth rate (CAGR), from $134.64M to $168.3M.
What does cash, cash equivalents, and marketable securities mean?
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.